Verastem, Inc. (VSTM)
Data as of , from SEC Form 4 filings.
See up to 3 months of VSTM. The 7-day demo opens the 1M and 3M ranges and puts VSTM on your watchlist.
Start 7-day demoLatest VSTM insider trades
About Verastem, Inc. (VSTM)
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
- NEEDHAM, MA
- 102
- 2012
- XNAS
VSTM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 48,044 | $381K |
| Grant or award | 2 | 115,226 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VSTM insider transactions (Form 4)
1339 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dan Paterson - Officer | Open-market sale | Common Stock | 390 | $9.99 | $4K | |
 Robert E. Gagnon - Director | Open-market sale | Common Stock | 281 | $9.99 | $3K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 1,332 | $5.81 | $8K | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 65 | $4.34 | $282 | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 28 | $3.91 | $109 | |
| Brian M. Stuglik - Director | Open-market sale | Common Stock | 595 | $4.54 | $3K | |
| Brian M. Stuglik - Director | Open-market sale | Common Stock | 334 | $4.37 | $1K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 244 | $4.54 | $1K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 183 | $4.37 | $800 | |
| Robert E. Gagnon - Director | Open-market sale | Common Stock | 285 | $4.54 | $1K | |
| Robert E. Gagnon - Director | Open-market sale | Common Stock | 130 | $4.37 | $568 | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 812 | $3.84 | $3K | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 6 | $2.86 | $17 |
Recent VSTM Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dan Paterson | Officer, Director | 44,121 | $353K | View on EDGAR | |
| - | - | - |
VSTM insider trading FAQ
What is the latest insider trade for VSTM?
Verastem, Inc. (VSTM) had 4 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for VSTM runs to 39 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VSTM stock?
No insider purchases of VSTM were filed in the last 90 days.
How many insiders are selling VSTM stock?
4 insider sales of VSTM were filed in the last 90 days, totaling $381K.
Where can I see VSTM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VSTM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dan Paterson view on EDGAR
- - Daniel Calkins view on EDGAR
- - Daniel Calkins view on EDGAR
- - Dan Paterson view on EDGAR
- - Dan Paterson view on EDGAR
- - Daniel Calkins view on EDGAR
- - Michael P. Bailey view on EDGAR
- - Karin Anna Tollefson view on EDGAR
- - Brian M. Stuglik view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where VSTM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VSTM with a 7-day demo
- VSTM on your watchlist
- Every VSTM Form 4 filing on record
- Up to 3 months of VSTM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
